iRhythm (IRTC) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does iRhythm (IRTC) do?
iRhythm Holdings Inc (IRTC) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures wearable biosensor patches that continuously record patient heart rhythms for up to two weeks. Pairs wearable cardiac patches with cloud-based algorithms to analyze heartbeat data for physicians. It is worth $3.17B on the market and sold $853.95M over the last year.
- Market cap
- $3.17B
- P/E ratio
- None (reported a loss)
- Annual sales
- $853.95M
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 19, 2026
Brands and businesses behind IRTC
- Zio: Sells wearable continuous cardiac monitoring patches and algorithmic data analysis services to medical clinics and hospitals.
IRTC’s flags, in plain English
Each flag is a number from iRhythm’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Wide Gross Margin
Gross margin of 72.3% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Stupid Cash
Can pay this year's bills 3.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Still Climbing
Sales up 23% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Debt Is Driving
Heavy debt, 410% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
1 more risk note open with the free trial. Try it free for 7 days.
Questions about IRTC
How big is iRhythm?
iRhythm’s market cap is $3.17B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $853.95M: what customers paid the company over the last year, before any costs.
What is IRTC’s P/E ratio?
IRTC has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with IRTC?
The business depends heavily on third-party insurance reimbursement rates that face ongoing pricing pressure and periodic cuts. That is one risk on iRhythm’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From iRhythm’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. IRTC’s filings on SEC.gov. The Margin Monkey is research, not advice.
